HIV and YOU. Special 2008 Update!

Similar documents
HIV Drugs and the HIV Lifecycle

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

HIV medications HIV medication and schedule plan

Genotyping and Drug Resistance in Clinical Practice. Case Studies

HIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options

OB/GYN CHART REVIEW DRAFT: NOT FOR DISTRTIBUTION

Midwestern Underwriting Conference 2016

HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

HIV THERAPY STRATEGIES FOR FIRST LINE. issues to think about when going on therapy for the first time

WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM

Adherence Strategies for Older Adults. AIDS Community Research Initiative of America (ACRIA)

WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION

Starting HIV Treatment


HIV Drug Resistance. Together, we can change the course of the HIV epidemic one woman at a time.

Part 2 of our 3 part series! Making MEDS Work for You

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Lesson 3: HIV Poverty

HIV Management Update 2015

What Women Need to Know: The HIV Treatment Guidelines for Pregnant Women

treatment VIRAL SUPPRESSION SUPPORT ART IS THE ONLY WAY TO CONTROL HIV TIPS FOR TAKING ART ADHERENCE Benefits of ART Start Know Your ARVs today ARVs

Starting HIV Treatment

Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care

Antiretroviral Dosing in Renal Impairment

HIV Integrase Inhibitors: Current and Future Use. Douglas G. Fish, MD Albany Medical College Cali, Colombia March 13, 2008

How HIV Works in Your Body

ADAP Monitoring Provider Prescribing Patterns. Amanda Bowes, NASTAD Christine Rivera and Dr. Charles Gonzalez, NYS AIDS Institute

HIV Treatment Guidelines

0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920

Nothing to disclose.

May 2016 P & T Updates

AIDS Drug Assistance Program ADAP-Miami. NEEDS ASSESSMENT July 16, 2010

treatment passport 1

Important Safety Information About TRUVADA to Reduce the Risk of Getting Human Immunodeficiency Virus 1 (HIV-1) Infection

NON-OCCUPATIONAL POST EXPOSURE PREVENTION. when you think you were exposed to hiv within the past three days

Nobel /03/28. HIV virus and infected CD4+ T cells

CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...

October 26-28: Training Day 1

HIV Clinical Nurse Specialist CCDHB Wellington

Projeto Praça Onze Universidade Federal do Rio de Janeiro. Long term treatment of chronic viral disease: lessons from HIV for HBV

Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) in the Long Term Care Setting Part 2: HIV Medications

Daclatasvir (Daklinza ) Drug Interactions with HIV Medications

ANTIRETROVIRAL TREATMENTS (Part 1of

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO

An HIV Update Jan Clark, PharmD Specialty Practice Pharmacist

BHIVA ART Guideline 2014 update: SEARCH PROTOCOL: main databases search

PATIENT INFORMATION EMTRIVA

Rapid Review Response HIV Medication and Depression

ALABAMA S ADAP FORMULARY OFFERS 117 MEDICATIONS

P.I. Perspective. December 2008, Issue #47. Information, Inspiration and Advocacy for People Living with HIV/AIDS

LET S TALK about Sticking with your treatment plan

continuing education for pharmacists

A Fatal Imbalance. Tropical diseases: 18 new drugs (incl. 8 for malaria) 1.3% 21 new drugs for neglected diseases. Tuberculosis: 3 new drugs

PATIENT INFORMATION EMTRIVA

Antiretrovial Crushable/Liquid Formulation Chart

World AIDS Day Year-by-Year Milestones in HIV/AIDS. healthlibrary

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 3 November 2010

Medscape's Antiretroviral Pocket Guide for the Treatment of HIV Infection

New York State Department of Health HIV Uninsured Care Programs

Terapia antirretroviral inicial y de rescate: Utilidad actual y futura de nuevos medicamentos

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 9 May 2012

FORMULARY Virginia (VA) AIDS Drug Assistance Program (ADAP) LAST UPDATED: December At a Glance: VA ADAP Formulary

Fluconazole dimenhydrinate, diphenhydramine. Raltegravir or dolutegravir with antacids

Strategies for HIV treatment

U P D AT E. contents. winter 2006/07

Appropriate Use & Safety Edits

PROGRESSIVE MULTI-FOCAL LEUKOENCEPHALOPATHY

HIV Infection & AIDS in Low- and Middle-Income Countries

Drug Treatment Program Update

Understanding HIV Basics. Author: Tricia Smith, Canadian AIDS Treatment Information Exchange

HIV Pharmacology 101ish - 202ish: New HIV Clinicians Workshop

Human Immunodeficiency Virus Infection A Modern Day Epidemic

The Future of HIV: Advances in Drugs and Research. Shauna Gunaratne December 17, 2018

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

Guide to changing treatment:

P.I. Perspective. Twenty-five Years in the Fight Against AIDS: What Have We Learned? October 2006, Issue #42

Approach for the Newly Diagnosed HIV Positive Patient

NATAPNATIONAL. HIV 102: Care & Treatment AIDS TREATMENT ADVOCACY PROJECT. Origins of HIV. Table of Contents. National AIDS Treatment Advocacy Project

Selecting an Initial Antiretroviral Therapy (ART) Regimen

The ART of Antiretroviral Therapy in Critically-ill Patients with HIV

COMPREHENSIVE ANTIRETROVIRAL TABLE: ADULT DOSING, DOSAGE FORM MODIFICATIONS, ADVERSE REACTIONS and INTERACTION POTENTIAL

Objectives. HIV Treatment in Recently In 1996 the introduction of protease inhibitors decreasing the death rate of those infected by 50%.

Guide to changing ART:

PATIENT INFORMATION VIREAD

PATIENT INFORMATION BOOKLET

Informed Consent Flipchart. Version 1.0, 30 Jan 2018

what's with it? GOT TO DO [Pharmacokinetics] [Pharmacokinetics] Non-Nukes and PIs: Do They Play Well Together? / Top 3 Websites Winter 2005

Addressing Pediatric Needs of the Most Neglected: next steps

Bruce A. Luxon, MD, Ph.D. Anton and Margaret Fuisz Chair in Medicine Professor and Chair Department of Medicine Georgetown University

image Empower Yourself With Knowledge for managing advanced prostate cancer

Information, inspiration and advocacy for people with HIV/AIDS and hepatitis C

JULUCA (dolutegravir sodium-rilpivirine hydrochloride) oral tablet

Approach to a Patient Newly Diagnosed with HIV, Including ART Basics Rajesh T. Gandhi, M.D.

Part 1 of our 3 part series! Making MEDS Work for You

P.I. Perspective. To nuke, or not to nuke? April 2007, Issue #43. Information, Inspiration and Advocacy for People Living with HIV/AIDS CONTENTS

Human Immunodeficiency Virus (HIV)

Important Safety Information for Adolescents Who Don t Have HIV

Starting points. living with HIV

Transcription:

HIV and YOU Special 2008 Update!

HIV and You Special 2008 Update! In this booklet, you ll see words in bold, red type. Go to the Glossary on the back cover to find out what these words mean. WRITERS AND EDITORS: Lillian Thiemann Co-Founder and President Visionary Health Concepts Editor-in-Chief www.freehivinfo.com, www.freehepatitisinfo.com Gardiner, NY Krista Martel Vice President Visionary Health Concepts Editor-in-Chief, VHComics Brooklyn, NY Are you experienced? Every person has life experiences. What does this mean? Flip through an old photo album, and what do you see?...your first love...a family vacation...the birth of a child...a loved one who has passed on Robert Munk, PhD Research Assistant Professor University of NM Department of Internal Medicine Coordinator AIDS InfoNet (www.aidsinfonet.org) Arroyo Seco, NM SCIENCE EDITOR: Daniel Kuritzkes, MD Director of AIDS Research Brigham and Women s Hospital Professor of Medicine Harvard Medical School Boston, MA Art Direction: DZP Illustrations: Chuck Gonzales This independent educational program was supported through a grant from Virco Lab, Inc. Not all of our experiences are in our photo albums. There are days we d rather not remember like the day that we found out we have HIV. Visionary Health Concepts, New York 2008 50% recycled paper (20% post-consumer waste) using soy-based inks. This booklet is a publication of Visionary Health Concepts. No other entity had any involvement in the production or editorial content. All of the experiences that have happened to us in our lifetime make us who we are and make up our personal history.

Are your HIV and you treatment experienced? Like you, each HIV virus also has experiences and a history. HIV is passed from one person to the other. It can enter the body directly through the blood and other bodily fluids such as semen, vaginal fluid and breast milk. 998 2003 2005 2007 So what is resistance? The basic HIV virus is called wild type. HIV drug resistance happens when the wild type HIV changes enough to allow HIV to make copies of itself even though you are taking anti-hiv drugs. The changes HIV goes through that helps resistance to happen are called mutations. Aww, Memories... Sometimes the HIV passed on to you can resist certain anti-hiv drugs. This means your HIV has treatment experience. A person who has taken more than one set of drugs to fight their HIV is also said to be treatment experienced. WILD TYPE HIV (Regular HIV) MUTANT HIV It is important to choose every anti-hiv regimen with care, even the first one (see page ). It is very important to know that it is the virus that s resistant not the drug, and NOT the patient! 2 3

How do you know if your HIV is becoming resistant to the drugs you are taking? What you should know about resistance tests Blood tests are taken when you visit the clinic. From that blood sample certain things are looked at Viral load: checks to see how much HIV is in your blood: A low viral load or one that is too low to measure (undetectable) means there is very little HIV found in your blood and the drugs are winning the fight against HIV. A high viral load (or a viral load that goes up with each test) might mean either: () HIV is winning the fight and the drugs you are taking are not working OR (2) you are not taking the drugs the way you need to. HIV Guidelines are documents used by healthcare providers to guide how they go about treating HIV. In December 2007, the US Department of Health and Human Services (DHHS) updated their HIV treatment guidelines (for adults). They advise that persons with HIV infection get a resistance test when entering care, even when HIV treatment is not started right away. If treatment is put off, then a second resistance test should be taken before starting anti-hiv drugs. Before changing anti-hiv drugs, a resistance test should be taken to help find out which drugs will (or will not) work well for you. 2 CD4+ T-cell count: looks at the number of CD4 cells in a tiny sample of blood. If your CD4 count is going down, it is a sign that HIV is starting to win the fight for your health. There are 2 basic types of resistance tests that can be done: A genotype test (or genotypic assay) looks at what physical changes (mutations) your HIV has gone through. Then they look to see if the changes are ones that are known to cause resistance to any anti-hiv drugs. The guidelines recommend a genotypic test for people who have never taken anti-hiv drugs before (also known as treatment naïve). A phenotype test shows how your HIV acts when it is faced with anti-hiv drugs. This test looks to see if HIV can still make copies of itself when you are taking an anti-hiv regimen, and how much. Drug resistance testing ask 3 Resistance tests: check to see if your HIV has changed (mutated) or if it is acting differently 4 than before (page 5). your doctor. 5

HIV Resistance Map Be sure to let the doctor know about all other medicines, drugs, supplements or herbs you take. Blood test to check state of health, CD4+ T-cell count and HIV viral load. Write down a list of the names of the anti-hiv drugs you start taking (your HIV treatment experience). Have HIV checked for resistance before starting anti-hiv treatment (usually a genotype test is done). You know your treatment is working when your viral load stays down and CD4+ T-cell count goes up. Check blood often to track T-cells and HIV viral load. Use at least two active drugs. Ask your doctor about powerful new drugs that work against proteaseresistant and non nucleoside (NNRTI)- resistant HIV that have joined these classes. Two new classes are also now available: CCR5 antagonists and integrase inhibitors. Try to find an expert in HIV drug resistance to discuss your treatment experience and get advice about your treatment options. HIV Status First Regimen During Low-Level Experience Mid-Level Experience High-Level Experience ( st and 2 nd regimen) (2 nd and 3 rd regimen) (3 rd, 4 th, 5 th regimen) Find an HIV expert to discuss your options. Get regular check-ups. HIV guidelines recommend getting a resistance test, even if not starting anti-hiv treatment right away. Get help to learn how to make anti-hiv meds part of your daily routine and take every dose, every day. Plan how to deal with side effects that might happen If your viral load goes up, check for HIV resistance while still taking anti-hiv drugs or within 4 weeks of stopping. (Usually a phenotype test is done in addition to a genotype test or sometimes it is done by itself.) Find out why treatment failed and try to fix it. Increase power of regimen or change drugs before resistance Plan goals for treatment that help you to stay alive while scientists work on a cure. 6 builds up. 7 so you do not miss doses!

Questions to ask your doctor BEFORE starting or changing HIV treatment Q: Q: What is my CD4 and viral load count? Helpful tip: Make a note of the first (baseline) results of your CD4+ T-cell count and viral load test before starting treatment. This way you can see with your next blood test if they change and how much. The new drugs should make your viral load go down and stay down. CD4 count should then go up. Make sure that HIV viral load and CD4+ T-cells are checked at least every 3 months. Is my HIV already resistant to any anti-hiv drugs? The doctor tells you your virus is resistant, now what? You are not alone! HIV drug resistance is the biggest reason anti-hiv drugs stop working. 3 out of 4 people on failing HIV treatment have drug-resistant HIV. Helpful tip: Keep in mind that resistant HIV can be passed from one person to another. Guidelines now recommend that a baseline resistance test be done even if you are not ready to start anti-hiv treatment. Q: What do I do if my viral load starts to go up? Up to out of 4 people with HIV who have never taken anti-hiv drugs already may have HIV that is drug resistant. Helpful tip: If your viral load goes up two times in a row, find out WHY the drugs are not working Take every dose on time: Ask yourself if you have been forgetting to take your drugs. Missing doses can give your 2 Make a list of ANY drugs, medicines or herbs HIV a chance to go up in your doctor may not know you are using. number. The more HIV in your body, the bigger the 3 Get an HIV resistance test before planning your next treatment move. risk of resistance. 8 9

Treating your mutant HIV Anti-HIV drug options Sometimes the anti-hiv drugs you are taking are just not strong enough or right for the job. Anti-HIV drugs with more power or different resistance patterns (see chart page 2-3) might be needed to take control of your HIV. Powerful new drugs that work against protease (PI)- resistant and non nucleoside (NNRTI)-resistant HIV have joined the protease inhibitor and NNRTI classes. Two new classes are also now available: CCR5 antagonists and integrase inhibitors. Just think of your body as the hottest club in town, and you and your doctor as the door guys deciding who goes in and who stays out. You don t want to let any old drug into your body. You want to make sure it s going to work. Unlike 6 years ago, there are now many anti-hiv drugs to choose from. It is still very important to choose your anti-hiv regimens carefully and take the drugs when and how you are supposed to. Put together three or four anti-hiv drugs in a regimen to be taken twice or sometimes even just once every day. Pick drugs for your regimen from at least two different classes to start. If you are treatment experienced, and have taken 2, 3, or even 4 regimens already, you probably have HIV that is resistant to some drugs. The good news is that there are some new drugs that fight HIV in different ways and will WORK against your drug-resistant HIV! 0 2 992 2008

HIV DRUGS and their resistance patterns The following chart lists the brand names of all current HIV drugs grouped by class (updated March 2008). It also shows very generally where single changes (mutations) and groups of changes that form a resistance pattern are similar among drugs and where they are not. Such changes can lessen the effectiveness of several HIV drugs, or in some cases, make the drugs affected totally helpless to assist in the fight against mutant HIV. 2 Nucleoside Reverse Transcriptase Inhibitors (nukes) Atripla (Viread + Emtriva + Sustiva) Combivir (Retrovir + Epivir) Emtriva Epivir Epzicom (Ziagen + Epivir) Retrovir Trizivir (Retrovir + Epivir + Ziagen) Truvada (Viread + Emtriva) Videx VidexEC Viread Zerit Ziagen Non Nucleoside Reverse Transcriptase Inhibitors (non nukes) Intelence Rescriptor Sustiva Viramune Atripla (Viread + Emtriva + Sustiva) 3 drugs from 2 HIV drug classes (2 nukes + non nuke) 2 nukes 2 nukes 3 nukes 2 nukes 3 drugs from 2 classes (2 nukes + non nuke) Resistance type(s) Shares major non nuke mutation K03N plus common nuke mutations. Share common nuke mutations. Resistance Type(s) Does not share primary common resistance mutation K03N with other non nukes. Share the major non nuke mutation K03N. Shares major non nuke mutation K03N plus common nuke mutations. Protease Inhibitors Aptivus Crixivan Invirase Kaletra (Norvir + lopinavir) Lexiva Norvir Prezista Reyataz Viracept Fusion Inhibitor Fuzeon CCRS Antagonist Selzentry Integrase Inhibitor Isentress 2 protease inhibitors Resistance type(s) It generally takes many more mutations to make HIV resistant to this newer protease inhibitor. Share similar resistance patterns with most other protease inhibitors. It generally takes many more mutations to make HIV resistant to this newer protease inhibitor. Share similar resistance patterns with most other protease inhibitors. Resistance Type(s) Does not share resistance patterns with any other HIV drugs (from any class). Resistance Type(s) Does not share resistance patterns with any other HIV drugs (from any class). Resistance Type(s) Does not share resistance patterns with any other HIV drugs (from any class). 3

Glossary Baseline: The results of the first test you take (for example, CD4 T-cell count). Your baseline number is helpful to compare against future results of the same test. CD4+ cells are also called T-cells. They are cells in the body that help fight disease and infection. HIV destroys CD4 cells. Your CD4+ T-cell count is the number of CD4 cells in a tiny sample of blood. If your CD4 count is too low, it is hard for your body to fight off disease. Class is a term for a group or family of drugs that work in a similar way. Nucleoside reverse transcriptase inhibitors, non nucleoside reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, CCR5 antagonists and integrase inhibitors are the six approved classes of anti-hiv drugs. Genotype: A way of reading the clues in the virus that tell us if the virus is changing (and if it is, how it s changing). HIV stands for Human Immunodeficiency Virus, the virus that causes AIDS. HIV expert: A doctor who mainly studies HIV disease and sees a lot of HIV+ patients. HIV drug resistance happens when the virus has changed itself (mutated) enough to grow in number by making copies of itself even though you are taking anti-hiv drugs. Mutation: HIV makes mistakes or changes when making copies of itself. These changes are called mutations. Some mutations can make it harder for anti-hiv drugs to control the virus. NNRTI: An abbreviation of Non-Nucleoside Reverse Transcriptase Inhibitor also known as non-nuke. The NNRTI class is one of six different classes of drugs that are used together in combination (or cocktail) to fight HIV. Phenotype: How HIV acts when faced with anti-hiv drugs can it make copies of itself or not? Protease inhibitor (PI) is one of six different classes of drugs that are used together in combination (or cocktail) to fight HIV. Regimen: A drug, or combination of drugs, that a person takes to treat their disease. Resistance test: A blood test that detects HIV drug resistance and helps rule out drugs that may not work for you. HIV guidelines recommend getting a resistance test, even if not starting anti-hiv treatment right away. Semen: Male sex fluid. Side effect: An unwanted result of a treatment. is another term for a drug, regimen, or a way of fighting a disease. experience: A person s history of what drugs or actions have been taken to fight a disease. Vaginal fluid: Female sex fluid. Viral load is the amount of HIV in a tiny sample of blood. Blood tests that look at a person s HIV viral load should be done about every 3 months. Wild type: Virus that has not been changed by meeting anti-hiv drugs before. Independent resistance news for providers Visit www.freehivinfo.com for the latest in cutting-edge, easy-to-understand education for consumers www.resistancereporter.com